Airway Inflammation News and Research

RSS

Certain dietary fats found to trigger hard-to-treat asthma in children

Researchers at Children's Hospital of Philadelphia (CHOP) found that certain lipids, or fats, in obesity-causing foods also cause asthma-like lung inflammation.

27 Aug 2025

Why zinc may be the missing nutrient in childhood asthma care

The role of zinc in childhood asthma is critical; deficiency may worsen symptoms, while supplementation could provide a safe, effective treatment alternative.

19 Aug 2025

Agricultural dust exposure may pose significant risks to gut health

Inhaling agricultural dust may pose significant risks to gut health for workers in animal agriculture, a University of California, Riverside, study has found.

18 Jul 2025

Home rehab program improves lung function in bronchiectasis

Findings reveal that a structured home rehabilitation program boosts lung function and quality of life in bronchiectasis patients, reducing acute exacerbations.

18 Jul 2025

Nasal antibody spray shields mice from pollen-triggered allergies and asthma

Intranasal delivery of a monoclonal IgG1 antibody targeting mugwort pollen protected mice from allergic rhinitis and asthma symptoms, without lowering systemic IgE levels. This localized, non-invasive approach dampened Th2 inflammation and preserved healthy airway tissue in sensitized mice.

14 Jul 2025

Brensocatib once-daily pill shows benefits for chronic lung disease

Results of a large, global clinical trial spanning five continents with over 1,700 patients with bronchiectasis, published this April in the New England Journal of Medicine, demonstrated benefits of an investigational, once-a-day pill called brensocatib as a therapy for the chronic lung condition.

30 Apr 2025

Best time for asthma meds? Try 4 pm

Chronotherapy for asthma reveals that afternoon inhaled corticosteroids significantly improve lung function and reduce nighttime symptoms without side effects.

17 Apr 2025

Mid afternoon inhaler use may improve nighttime asthma control

A single daily preventer dose of inhaled corticosteroid (beclomethasone), taken mid afternoon, may be the best timing for effective asthma control as it suppresses the usual nocturnal worsening of symptoms more effectively than dosing regimens at other times of the day, suggest the results of a small clinical trial published in the journal Thorax.

15 Apr 2025

Afternoon could be best time for asthma inhaler, study shows

A mid-afternoon puff could be the best way to get the most out of your asthma inhaler according to a new study led by University of Manchester researchers.

15 Apr 2025

New data highlights urgent need for better asthma care – How FeNO testing can help reduce hospitalizations

Bedfont® calls for wider FeNO testing adoption to improve asthma care, reduce emergency visits, and ensure timely treatment for better respiratory health.

From NObreath 9 Apr 2025

Bedfont® Scientific Limited highlights FeNO testing’s role in childhood asthma for World Health Day 2025

As the world prepares to observe World Health Day on April 7th, 2025, Bedfont® Scientific Limited highlights the importance of early and accurate asthma diagnosis with its innovative NObreath® Fractional exhaled Nitric Oxide (FeNO) device.

From NObreath 2 Apr 2025

Dry air exposure linked to dehydration and inflammation in human airways

In a recent, cross-institutional study partially funded by the National Institutes of Health, researchers report that healthy human airways are at higher risk for dehydration and inflammation when exposed to dry air, an occurrence expected to increase due to global warming.

17 Mar 2025

Early immune system changes contribute to lung damage in cystic fibrosis

Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers from the Technical University of Munich (TUM) have discovered that the disease causes changes in the immune system early in life, presumably even in newborns.

7 Feb 2025

Cigarette smoke alters immune cell function in the lungs

Cigarette smoking is widespread and deadly, yet our understanding of how cigarette smoke actually causes serious respiratory illnesses is incomplete, which has severely hampered the development of effective treatments.

17 Jan 2025

Granzyme K+ CD8+ T-cells identified as key drivers of recurrent airway inflammation

Researchers identify a pathogenic subset of CD8+ memory T-cells that promote airway tissue inflammation and recurrent respiratory diseases.

17 Jan 2025

Study reveals how cigarette smoke weakens immune cells in the lungs

15 Jan 2025

Bedfont® Scientific Limited Brings Cutting-Edge Respiratory and Gastrointestinal Diagnostic Solutions to Saudi Arabia with New Registration

With the launch of NObreath® FeNO and Gastrolyzer® devices, Bedfont® and Tebaba Medical Services are advancing breath analysis technology in the Middle East.

From NObreath 3 Dec 2024

Empowering Asthma Care: Bedfont® Scientific Limited Provides Vital Support for FeNO Testing in Response to Updated NICE Asthma Guidelines

The latest NICE guidelines on asthma emphasize FeNO testing. Bedfont® provides resources and support for healthcare professionals implementing these changes.

From Bedfont® Scientific Ltd 29 Nov 2024

Diabetes drugs cut asthma attacks by up to 70%, reshaping treatment options

Metformin and GLP-1 receptor agonists significantly reduce asthma attacks in patients with type 2 diabetes, offering potential new treatments for asthma.

19 Nov 2024

New study confirms: Anti-inflammatory inhalers reduce severe asthma complications

This study highlights the benefits of anti-inflammatory inhalers in asthma management, showing reduced complications and modest improvements in symptom control.

30 Oct 2024